SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sarah Picaud, Maria Strocchia, Stefania Terracciano, Gianluigi Lauro, Jacqui Mendez, Danette L. Daniels, Raffaele Riccio, Giuseppe Bifulco, Ines Bruno, Panagis Filippakopoulos, 9H-Purine Scaffold Reveals Induced-Fit Pocket Plasticity of the BRD9 Bromodomain, Journal of Medicinal Chemistry, 2015, 58, 6, 2718

    CrossRef

  2. 2
    Ryuji Hamamoto, Vassiliki Saloura, Yusuke Nakamura, Critical roles of non-histone protein lysine methylation in human tumorigenesis, Nature Reviews Cancer, 2015, 15, 2, 110

    CrossRef

  3. 3
    Kornelius Schulze, Jessica Zucman-Rossi, Current issues on genomic heterogeneity in hepatocellular carcinoma and its implication in clinical practice, Hepatic Oncology, 2015, 2, 3, 291

    CrossRef

  4. 4
    Jessica Zucman-Rossi, Augusto Villanueva, Jean-Charles Nault, Josep M. Llovet, Genetic Landscape and Biomarkers of Hepatocellular Carcinoma, Gastroenterology, 2015,

    CrossRef

  5. 5
    Sophie C Cazanave, Arun J Sanyal, KEAP the balance between life and death, Molecular & Cellular Oncology, 2015, 2, 2, e968065

    CrossRef

  6. 6
    Jens U Marquardt, Jesper B Andersen, Liver cancer oncogenomics: opportunities and dilemmas for clinical applications, Hepatic Oncology, 2015, 2, 1, 79

    CrossRef

  7. 7
    Carla Frau, Roberto Loi, Annalisa Petrelli, Andrea Perra, Silvia Menegon, Marta Anna Kowalik, Silvia Pinna, Vera Piera Leoni, Francesca Fornari, Laura Gramantieri, Giovanna Maria Ledda-Columbano, Silvia Giordano, Amedeo Columbano, Local hypothyroidism favors the progression of preneoplastic lesions to hepatocellular carcinoma in rats, Hepatology, 2015, 61, 1
  8. 8
    E Callegari, L Gramantieri, M Domenicali, L D'Abundo, S Sabbioni, M Negrini, MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches, Cell Death and Differentiation, 2015, 22, 1, 46

    CrossRef

  9. 9
    Patrizia Zavattari, Andrea Perra, Silvia Menegon, Marta Anna Kowalik, Annalisa Petrelli, Maria Maddalena Angioni, Antonia Follenzi, Luca Quagliata, Giovanna Maria Ledda-Columbano, Luigi Terracciano, Silvia Giordano, Amedeo Columbano, Nrf2, but not β-catenin, mutation represents an early event in rat hepatocarcinogenesis, Hepatology, 2015, 62, 3
  10. 10
    Tao Jiang, Bryan Harder, Montserrat Rojo de la Vega, Pak K. Wong, Eli Chapman, Donna D. Zhang, p62 links autophagy and Nrf2 signaling, Free Radical Biology and Medicine, 2015,

    CrossRef

  11. 11
    Matthew M. Yeh, Yajuan Liu, Michael Torbenson, Steatohepatitic Variant of Hepatocellular Carcinoma in the Absence of Metabolic Syndrome or Background Steatosis: a Clinical, Pathological and Genetic Study, Human Pathology, 2015,

    CrossRef

  12. 12
    Antoine Hollebecque, David Malka, Charles Ferté, Michel Ducreux, Valérie Boige, Systemic treatment of advanced hepatocellular carcinoma: From disillusions to new horizons, European Journal of Cancer, 2015, 51, 3, 327

    CrossRef

  13. 13
    Sílvia Vilarinho, Tamar Taddei, Therapeutic Strategies for Hepatocellular Carcinoma: New Advances and Challenges, Current Treatment Options in Gastroenterology, 2015, 13, 2, 219

    CrossRef

  14. 14
    Ying-Hsiu Su, Selena Y Lin, Wei Song, Surbhi Jain, DNA markers in molecular diagnostics for hepatocellular carcinoma, Expert Review of Molecular Diagnostics, 2014, 14, 7, 803

    CrossRef

  15. 15
    Derek A. Mann, Epigenetics in liver disease, Hepatology, 2014, 60, 4
  16. 16
    Capucine Van Rechem, Johnathan R. Whetstine, Examining the impact of gene variants on histone lysine methylation, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2014, 1839, 12, 1463

    CrossRef

  17. 17
    Jean-Charles Nault, Jessica Zucman-Rossi, Genetics of hepatocellular carcinoma: The next generation, Journal of Hepatology, 2014, 60, 1, 224

    CrossRef

  18. 18
    Sung-Min Ahn, Se Jin Jang, Ju Hyun Shim, Deokhoon Kim, Seung-Mo Hong, Chang Ohk Sung, Daehyun Baek, Farhan Haq, Adnan Ahmad Ansari, Sun Young Lee, Sung-Min Chun, Seongmin Choi, Hyun-Jeung Choi, Jongkyu Kim, Sukjun Kim, Shin Hwang, Young-Joo Lee, Jong-eun Lee, Wang-rim Jung, Hye Yoon Jang, Eunho Yang, Wing-Kin Sung, Nikki P. Lee, Mao Mao, Charles Lee, Jessica Zucman-Rossi, Eunsil Yu, Han Chu Lee, Gu Kong, Genomic portrait of resectable hepatocellular carcinomas: Implications of RB1 and FGF19 aberrations for patient stratification, Hepatology, 2014, 60, 6
  19. 19
    Maria Daoudaki, Ioannis Fouzas, Hepatocellular carcinoma, Wiener Medizinische Wochenschrift, 2014, 164, 21-22, 450

    CrossRef

  20. 20
    Xiuquan Du, Jiaxing Cheng, Identification and Analysis of Driver Missense Mutations Using Rotation Forest with Feature Selection, BioMed Research International, 2014, 2014, 1

    CrossRef

  21. 21
    Lucie Guetzoyan, Richard J. Ingham, Nikzad Nikbin, Julien Rossignol, Michael Wolling, Mark Baumert, Nicola A. Burgess-Brown, Claire M. Strain-Damerell, Leela Shrestha, Paul E. Brennan, Oleg Fedorov, Stefan Knapp, Steven V. Ley, Machine-assisted synthesis of modulators of the histone reader BRD9 using flow methods of chemistry and frontal affinity chromatography, MedChemComm, 2014, 5, 4, 540

    CrossRef

  22. 22
    Jonathan K Mitchell, David R McGivern, Mechanisms of hepatocarcinogenesis in chronic hepatitis C, Hepatic Oncology, 2014, 1, 3, 293

    CrossRef

  23. 23
    Shanshan Zou, Jiarui Li, Huabang Zhou, Christian Frech, Xiaolan Jiang, Jeffrey S. C. Chu, Xinyin Zhao, Yuqiong Li, Qiaomei Li, Hui Wang, Jingyi Hu, Guanyi Kong, Mengchao Wu, Chuanfan Ding, Nansheng Chen, Heping Hu, Mutational landscape of intrahepatic cholangiocarcinoma, Nature Communications, 2014, 5696

    CrossRef

  24. 24
    Silvia Vilarinho, Diego F. Calvisi, New advances in precision medicine for hepatocellular carcinoma recurrence prediction and treatment, Hepatology, 2014, 60, 6
  25. 25
    Jean-Charles Nault, Pathogenesis of hepatocellular carcinoma according to aetiology, Best Practice & Research Clinical Gastroenterology, 2014, 28, 5, 937

    CrossRef

  26. 26
    Gerald Goh, Ute I Scholl, James M Healy, Murim Choi, Manju L Prasad, Carol Nelson-Williams, John W Kuntsman, Reju Korah, Anna-Carinna Suttorp, Dimo Dietrich, Matthias Haase, Holger S Willenberg, Peter Stålberg, Per Hellman, Göran Åkerström, Peyman Björklund, Tobias Carling, Richard P Lifton, Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors, Nature Genetics, 2014, 46, 6, 613

    CrossRef

  27. 27
    Matthias S. Matter, Thomas Decaens, Jesper B. Andersen, Snorri S. Thorgeirsson, Targeting the mTOR pathway in hepatocellular carcinoma: Current state and future trends, Journal of Hepatology, 2014, 60, 4, 855

    CrossRef

  28. 28
    Jean Charles Nault, Julien Calderaro, Luca Di Tommaso, Charles Balabaud, Elie Serge Zafrani, Paulette Bioulac-Sage, Massimo Roncalli, Jessica Zucman-Rossi, Telomerase reverse transcriptase promoter mutation is an early somatic genetic alteration in the transformation of premalignant nodules in hepatocellular carcinoma on cirrhosis, Hepatology, 2014, 60, 6
  29. 29
    Melanie Eichenmüller, Franziska Trippel, Michaela Kreuder, Alexander Beck, Thomas Schwarzmayr, Beate Häberle, Stefano Cairo, Ivo Leuschner, Dietrich von Schweinitz, Tim M. Strom, Roland Kappler, The genomic landscape of hepatoblastoma and their progenies with HCC-like features, Journal of Hepatology, 2014, 61, 6, 1312

    CrossRef

  30. 30
    J.C. Nault, J. Zucman-Rossi, Pathobiology of Human Disease, 2014,

    CrossRef

  31. 31
    Adam Pennycuick, Augusto Villanueva, Signaling in hepatocellular carcinoma,